In addition to the increased incidence of IBD that we have discussed, other adverse events that have been reported at relatively low incidence with targeting the IL-17 family include neutropenia, noncutaneous infection, and depression with or without suicidality, although causality of the latter has been recently disproven [100–102]. This evidence concerns the gene IL17A and Decreased total neutrophil count.